Business Context and Reporting Period
Company: AMBEV S.A.
Filing Type: Form 6-K (Interim Consolidated Financial Statements)
Reporting Period: Nine months ended September 30, 2015 (compared to the same period in 2014).
Currency: Brazilian Reais (R$) in thousands.
Business Overview: Ambev produces and sells beer, soft drinks, and other beverages in Brazil and the Americas. The company is a subsidiary of Anheuser-Busch InBev N.V/S.A.
Key Financial Metrics
| Metric (Nine Months Ended Sep 30, 2015) | Value (R$ thousands) | Prior Period (Sep 30, 2014) |
|---|---|---|
| Net Sales | 31,423,915 | 25,846,901 |
| Gross Profit | 20,291,544 | 16,842,161 |
| Income from Operations (EBIT) | 11,732,647 | 9,767,267 |
| Net Income | 8,620,625 | 7,702,951 |
| Net Income Attributable to Ambev | 8,270,051 | 7,527,119 |
| Cash Flow from Operating Activities | 12,593,030 | 7,123,826 |
| Total Assets | 88,043,173 | 72,143,203 |
| Total Liabilities | 37,740,450 | 28,498,534 |
| Total Equity | 50,302,723 | 43,644,669 |
| Cash and Cash Equivalents | 9,680,857 | 9,722,067 |
| Interest-Bearing Loans (Total) | 2,985,521 | 2,622,623 |
Margins (Nine Months 2015):
- Gross Margin: 64.6%
- Operating Margin (EBIT): 37.3%
- Net Margin: 27.4%
- Normalized EBITDA Margin: 45.2%
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21.6% to R$31.4 billion, driven by volume growth and price increases, particularly in the Latin America North (Brazil) and South segments.
- Profitability: Net income rose 11.9% to R$8.6 billion. Operating income increased 20.1% to R$11.7 billion.
- Non-Recurring Items: The period included R$266.3 million in non-recurring expenses, primarily a R$239.1 million administrative lawsuit settlement (CADE antitrust fine) and R$27.2 million in restructuring costs. Excluding these, normalized EBIT was R$12.0 billion.
- Balance Sheet Expansion: Total assets grew 22% to R$88.0 billion, largely due to foreign exchange effects and acquisitions (e.g., Colombian companies). Goodwill increased to R$31.3 billion.
- Cash Flow: Operating cash flow surged 76.8% to R$12.6 billion, reflecting strong working capital management and higher net income.
- Dividends: The company distributed R$6.8 billion in dividends and interest on shareholder's equity during the nine-month period.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary & Outlook:
- The company reported no significant events for the nine-month period other than the CADE settlement.
- Capital expenditures remained steady at R$3.2 billion for the nine months, focused on capacity expansion.
- The company continues to optimize its capital structure to maximize shareholder value while maintaining financial flexibility.
Risks and Contingencies:
- Legal/Tax: Significant contingent liabilities exist regarding tax assessments (ICMS, IPI, PIS, COFINS) totaling approximately R$29.5 billion, though management classifies the likelihood of loss as "possible" rather than "probable" for most, hence no provision is recorded.
- Antitrust: The R$229 million CADE fine was settled in Q2 2015 and paid in installments.
- Financial Instruments: The company uses extensive derivatives (futures, swaps, forwards) to hedge foreign currency, interest rate, and commodity risks. Sensitivity analysis indicates potential losses in adverse scenarios, though hedging strategies are designed to mitigate these.
- Acquisitions: Post-period event: On October 9, 2015, Ambev acquired 100% of Mill Street Brewery in Canada.
Key Facts for Investor Verification
- Antitrust Settlement Impact: Verify the cash flow impact of the R$229 million CADE fine payment schedule (first installment paid August 2015, remaining in 2017-2020).
- Tax Contingencies: Review the R$29.5 billion in tax contingencies (Note 22) to assess potential future liabilities if "possible" losses become "probable."
- Foreign Exchange Exposure: Analyze the impact of currency fluctuations on the R$5.0 billion gain on translation of foreign operations recorded in Other Comprehensive Income.
- Dividend Policy: Confirm the sustainability of the R$6.8 billion distribution relative to the R$12.6 billion operating cash flow.
- Goodwill Valuation: Monitor the R$31.3 billion goodwill balance, particularly in light of the annual impairment testing scheduled for the fourth quarter.